Investor Relations

Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.

Latest News

Half year Report
02 December 2019

Notice of Results
26 November 2019

Half year trading update
22 October 2019

Share Price

Fusion Antibodies Company Profile

Read More »

Who We Are

Investor Videos

Watch latest video »

Investor Alert

Sign up for Investor Alerts »
close menu